Description

3-Pentenoicacid,2,5-Diamino-2-Methyl-,(+)-(9Ci) is a chiral, non-proteinogenic amino acid derivative with a unique unsaturated carbon backbone. This compound matters as a versatile and high-value pharmaceutical intermediate and chiral building block for the synthesis of complex bioactive molecules. It is primarily needed by research institutions and manufacturers in the pharmaceutical, agrochemical, and specialty chemical industries for developing new active ingredients and fine chemicals.

Application

• Pharmaceutical Intermediate: Key chiral synthon for the research and production of novel APIs (Active Pharmaceutical Ingredients), particularly in oncology and neurology.
• Agrochemical Synthesis: Building block for developing advanced herbicides, fungicides, and plant growth regulators with specific stereochemistry.
• Peptidomimetics Research: Used in medicinal chemistry to create peptide analogs and conformationally constrained scaffolds for drug discovery.
• Asymmetric Catalysis: Serves as a ligand precursor or a chiral auxiliary in stereoselective synthesis processes.
• Biochemical Research: Tool compound for studying enzyme mechanisms and metabolic pathways involving amino acid analogs.
• Fine Chemical Production: Intermediate for manufacturing specialty chemicals, flavors, and fragrances requiring high purity and specific isomerism.

Basic Information

Product Name	3-Pentenoicacid,2,5-Diamino-2-Methyl-,(+)-(9Ci)
CAS No.	111656-46-3
Molecular Formula	C6H12N2O2
Molecular Weight	144.17 g/mol
Synonyms	(+)-2,5-Diamino-2-methyl-3-pentenoic acid; (2R)-2,5-Diamino-2-methyl-3-pentenoic acid; D-2,5-Diamino-2-methyl-3-pentenoic acid; 2-Methyl-2,5-diamino-3-pentenoic acid; (R)-2-Amino-2-methyl-4-[(amino)methylene]butanoic acid; 3-Pentenoic acid, 2,5-diamino-2-methyl-, (R)-; (R)-2,5-Diamino-2-methylpent-3-enoic acid
EINECS	Contact for details

Quality Control

Our 3-Pentenoicacid,2,5-Diamino-2-Methyl-,(+)-(9Ci) is produced under strict quality management systems. Every batch undergoes rigorous analytical testing, including chiral purity assessment by HPLC, to ensure it meets the high standards required for pharmaceutical R&D and cGMP applications. A comprehensive Certificate of Analysis (COA) detailing identity, purity, enantiomeric excess, and impurity profiles is provided with each shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept under an inert atmosphere (e.g., nitrogen or argon) after opening to prevent degradation. For long-term storage, consider storing at 2-8°C.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Enantiomeric Purity (Chiral HPLC)	≥ 99.0% ee
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals (as Pb)	≤ 10 ppm
Related Substances (HPLC)	Total impurities ≤ 1.0% Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.